Back to Search
WILLIAM BERRY, M.D.
M.D.
Family Medicine Physician
NPI: 1841227071IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Class of 1975
Research & Publications (20)
Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy.
PMID 19633050·Ann Oncol·2010
3-trial
Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials.
PMID 19633053·Ann Oncol·2010
8-other
An estimation of the global volume of surgery: a modelling strategy based on available data.
PMID 18582931·Lancet·2008
8-other
Results of a phase II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for the community-based clinic?
PMID 17364554·Cancer Invest·2007
3-trial
Spontaneously occurring fibroid tumors of the laying hen oviduct.
PMID 17032831·Poult Sci·2006
7-preclinical
The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer.
PMID 15939076·Urology·2005
6-review
Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy.
PMID 16368869·Oncologist·2005
6-review
Predicting the toxicity of chromium in sediments.
PMID 15648774·Environ Toxicol Chem·2004
7-preclinical
Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancer.
PMID 15479494·Clin Prostate Cancer·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 719 DETROIT STREET
DANVILLE, AR 72833 - Phone
- (479) 495-2241
Quick Facts
- NPI
- 1841227071
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 51
- Publications
- 20
Are you this provider?
Claim Your Profile